NOVO — Juni 2025

[ProinvestorNEWS]

Novo Nordisk: De første fulde fase 1 og 2-data for Amycretin https://proinvestor.com/boards/126885

[ProinvestorNEWS]

Højdosis Wegovy gav over 21% vægttab - 1/3 25% og derover https://proinvestor.com/boards/126888

[ProinvestorNEWS]

Novo Nordisk med 2 stærke datasæt https://proinvestor.com/boards/126893/

[bb8]

Muscle-preserving drugs could generate over $30 billion in sales by 2035, TD Cowen says - https://www.reuters.com/business/healthcare-pharmaceuticals/muscle-preserving-drugs-could-generate-over-30-billion-sales-by-2035-td-cowen-2025-06-20/ Reuters

[Milito]

“En kvinde med tre børn, hvordan mon det ville blive modtaget i det mindre progressive udland” Det er da godt nok en forældet og idiotisk tanke at have. Lisa Su, Jane Fraser, Mary Barra m.fl. er da velanset CEOs i store amerikanske virksomheder.

[pauly]

Vi skal have den der er bedst for NOVO, så er jeg ligeglad med om det er en trebenet mutant

[Occam]

h

[Occam]

Hvis Rebien ville have Meelby, kunne han have ansat hende for en måned siden.

[ProinvestorNEWS]

Lilly's oral GLP-1, orforglipron - data fra fase 3 https://proinvestor.com/boards/126900

[Craw]

Milito, Det er jeg såmænd enig i. Det kan også være, at jeg er for skeptisk ift. hvordan man tænker rundt omkring.

[JKY_VH]

Ærgerligt at Novo afviser https://ekstrabladet.dk/penge/fra-ozempic-til-ozem-pik-maend-jubler/10856045

[pauly]

Men det får da mænd til at tænke "hvis jeg nu tabte mig ville den se større ud"

[ProinvestorNEWS]

Novo Nordisk A/S: CagriSema 2.4 mg / 2.4 mg demonstrated 22.7% mean weight reduction in adults with overweight or obesity in REDEFINE 1, published in New England Journal of Medicine https://proinvestor.com/boards/126912

[nohope]

Et Novo pæparat der kunne give 1 " ville være mere værd end fedmemedicin.

[lahn1]

Mim8 prophylaxis treatment shown to be well-tolerated when switching from emicizumab in people with haemophilia A in new phase 3 data presented at the ISTH 2025 Congress https://www.novonordisk.com/news-and-media/news-and-ir-materials/news-details.html?id=916355#

[lahn1]

CagriSema 2.4 mg / 2.4 mg demonstrated 22.7% mean weight reduction in adults with overweight or obesity in REDEFINE 1, published in New England Journal of Medicine. https://www.novonordisk.com/news-and-media/news-and-ir-materials/news-details.html?id=916353

[Droogers]

Amycretinen ser godt nok lovende ud, selv sammenlignet med Retatrutide

[Helge_LarsenPI-redaktør]

Godmorgen

[ProinvestorNEWS]

Novo Nordisk: Stærke data kan vende stemningen, men sker det gradvist? https://proinvestor.com/boards/126925

[Helge_LarsenPI-redaktør]

Novo Nordisk A/S: Mim8 prophylaxis treatment shown to be well-tolerated when switching from emicizumab in people with haemophilia A in new phase 3 data presented at the ISTH 2025 Congress https://ml-eu.globenewswire.com/Resource/Download/d98c93a8-0cdb-4132-b631-8e59fc70244b